Regulations
SQZ Biotech lines up $75m IPO for cell therapy R&D
RegulationsSQZ Biotech lines up $75m IPO for cell therapy R&DSQZ Biotech lines up $75m IPO for cell therapy R&D
SQZ Biotechnologies says its technology can produce cell therapies in less than 24 hours compared to a month or more for current products.